Actively Recruiting
Evaluation of the Absence of Intraoperative Bladder Catheterization in Case of Planned Cesarean Section
Led by University Hospital, Montpellier · Updated on 2026-03-12
550
Participants Needed
2
Research Sites
249 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The hypothesis of this trial is that the absence of systematic bladder catheterization in patients performing spontaneous urination in the hour preceding the planned cesarean section under spinal anesthesia would not lead to more bladder heterocatheterization for postpartum urinary retention (RUPP) in the 24 hours post-cesarean section than systematic intraoperative bladder catheterization up to 2 hours post-surgery.
CONDITIONS
Official Title
Evaluation of the Absence of Intraoperative Bladder Catheterization in Case of Planned Cesarean Section
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patient
- Patient admitted for a planned cesarean section after 34 weeks under spinal anesthesia
- Single or twin pregnancy
- Unscarred or with one or two scars of the uterus
You will not qualify if you...
- Positive urine test strip showing nitrites or leukocytes the day before surgery indicating asymptomatic bacteriuria
- Emergency cesarean section
- Scheduled cesarean section delayed beyond 3 p.m. due to service organization
- Epidural anesthesia
- Contraindications to spinal anesthesia such as uncorrected hypovolemia, blood coagulation disorders, sepsis or severe inflammation at puncture site, neurological deficit, migraine pattern, spinal cord disease, spinal malformation, febrile syndrome
- ASA score 4 or higher
- Placental insertion abnormalities (placenta previa and/or accreta)
- Medical need for diuresis monitoring
- Oliguria or renal failure
- Use of intrathecal clonidine during scheduled cesarean
- History of bladder surgery or surgical urological pathology during pregnancy (including JJ catheter)
- History of complex abdominal surgery
- Inability to give free, informed, written consent after reflection period
- Not affiliated with or beneficiary of a national health insurance system
- Under legal protection, guardianship, or curatorship
- Participation in interventional drug research within 3 months before inclusion
- Current participation in another interventional research
- Exclusion period determined by another study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Montpellier University Hospital
Montpellier, France, 34295
Actively Recruiting
2
Nîmes University Hospital
Nîmes, France, 30029
Actively Recruiting
Research Team
A
Audrey LAMOUROUX, MD
CONTACT
L
Laura CRANTELLE, CRA
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here